Develops technologies for mapping and analyzing RNA modifications to advance research in gene regulation, disease, and personalized medicine.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Alida Biosciences develops advanced technologies and products for mapping and analyzing RNA modifications, enabling scientists to explore the epitranscriptome and its role in gene regulation and disease. Their EpiPlex™ platform and EpiScout™ analysis software provide seamless workflows for detecting and quantifying RNA modifications, supporting research in diagnostics, therapeutics, and personalized medicine.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Investors
FusionX Ventures
Genoa Ventures
Vertical Venture Partners
Alida Biosciences Valuations & Financials
View real-time NPM data on Alida Biosciences stock including daily Alida Biosciences stock price estimates, valuation history, and historical share price information. Access Alida Biosciences financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Alida Biosciences pricing across six independent market signals. Looking for private company due diligence data sources on Alida Biosciences? Get in touch to learn more.
Similar Companies
like Alida Biosciences
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
NAILBITER
AI & Machine Learning
Captures and analyzes real consumer behavior through video to deliver insights on shopping and purchase decisions.
Tire Agent
Commerce & Marketplaces
Online tire marketplace providing direct-to-customer delivery and optional professional installation services.
Strada
Enterprise Software
Delivers a platform that automates billing and revenue workflows while improving financial visibility and operational efficiency.
LinearB
Enterprise Software
Develops analytics software that improves engineering team productivity by optimizing workflows and software delivery performance.
Hadrius
FinTech
Develops technology that applies data science and machine learning to analyze markets and support investment decision making.
TrueAccord
FinTech
Drives debt recovery through automated, personalized digital engagement and self‑serve repayment options.
Trainual
Enterprise Software
Cloud-based platform streamlines employee training and onboarding by enabling businesses to create and manage standardized training workflows.
Full Harvest
Climate & Sustainability
Digitizing produce commerce to enable sale of surplus and imperfect harvests, turning would-be waste into value.
FAQ
We have answers
Alida Biosciences stock does not trade on public stock exchanges. Alida Biosciences stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Alida Biosciences stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Alida Biosciences Stock does not trade on public stock exchanges. In order to sell Alida Biosciences shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Alida Biosciences does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Alida Biosciences share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Alida Biosciences stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Alida Biosciences stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Alida Biosciences stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Alida Biosciences is a private company and has not had an IPO. There is currently no Alida Biosciences IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Alida Biosciences IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
